261 related articles for article (PubMed ID: 20837821)
1. Defective mitochondrial adenosine triphosphate production in skeletal muscle from patients with dominant optic atrophy due to OPA1 mutations.
Lodi R; Tonon C; Valentino ML; Manners D; Testa C; Malucelli E; La Morgia C; Barboni P; Carbonelli M; Schimpf S; Wissinger B; Zeviani M; Baruzzi A; Liguori R; Barbiroli B; Carelli V
Arch Neurol; 2011 Jan; 68(1):67-73. PubMed ID: 20837821
[TBL] [Abstract][Full Text] [Related]
2. Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.
Lodi R; Tonon C; Valentino ML; Iotti S; Clementi V; Malucelli E; Barboni P; Longanesi L; Schimpf S; Wissinger B; Baruzzi A; Barbiroli B; Carelli V
Ann Neurol; 2004 Nov; 56(5):719-23. PubMed ID: 15505825
[TBL] [Abstract][Full Text] [Related]
3. Secondary mtDNA defects do not cause optic nerve dysfunction in a mouse model of dominant optic atrophy.
Yu-Wai-Man P; Davies VJ; Piechota MJ; Cree LM; Votruba M; Chinnery PF
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4561-6. PubMed ID: 19443720
[TBL] [Abstract][Full Text] [Related]
4. Multi-system neurological disease is common in patients with OPA1 mutations.
Yu-Wai-Man P; Griffiths PG; Gorman GS; Lourenco CM; Wright AF; Auer-Grumbach M; Toscano A; Musumeci O; Valentino ML; Caporali L; Lamperti C; Tallaksen CM; Duffey P; Miller J; Whittaker RG; Baker MR; Jackson MJ; Clarke MP; Dhillon B; Czermin B; Stewart JD; Hudson G; Reynier P; Bonneau D; Marques W; Lenaers G; McFarland R; Taylor RW; Turnbull DM; Votruba M; Zeviani M; Carelli V; Bindoff LA; Horvath R; Amati-Bonneau P; Chinnery PF
Brain; 2010 Mar; 133(Pt 3):771-86. PubMed ID: 20157015
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial oxidative phosphorylation compensation may preserve vision in patients with OPA1-linked autosomal dominant optic atrophy.
Van Bergen NJ; Crowston JG; Kearns LS; Staffieri SE; Hewitt AW; Cohn AC; Mackey DA; Trounce IA
PLoS One; 2011; 6(6):e21347. PubMed ID: 21731710
[TBL] [Abstract][Full Text] [Related]
6. Genetic screening for OPA1 and OPA3 mutations in patients with suspected inherited optic neuropathies.
Yu-Wai-Man P; Shankar SP; Biousse V; Miller NR; Bean LJ; Coffee B; Hegde M; Newman NJ
Ophthalmology; 2011 Mar; 118(3):558-63. PubMed ID: 21036400
[TBL] [Abstract][Full Text] [Related]
7. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes.
Amati-Bonneau P; Valentino ML; Reynier P; Gallardo ME; Bornstein B; Boissière A; Campos Y; Rivera H; de la Aleja JG; Carroccia R; Iommarini L; Labauge P; Figarella-Branger D; Marcorelles P; Furby A; Beauvais K; Letournel F; Liguori R; La Morgia C; Montagna P; Liguori M; Zanna C; Rugolo M; Cossarizza A; Wissinger B; Verny C; Schwarzenbacher R; Martín MA; Arenas J; Ayuso C; Garesse R; Lenaers G; Bonneau D; Carelli V
Brain; 2008 Feb; 131(Pt 2):338-51. PubMed ID: 18158317
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial disorder with OPA1 mutation lacking optic atrophy.
Milone M; Younge BR; Wang J; Zhang S; Wong LJ
Mitochondrion; 2009 Jul; 9(4):279-81. PubMed ID: 19303950
[TBL] [Abstract][Full Text] [Related]
9. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance.
Hudson G; Amati-Bonneau P; Blakely EL; Stewart JD; He L; Schaefer AM; Griffiths PG; Ahlqvist K; Suomalainen A; Reynier P; McFarland R; Turnbull DM; Chinnery PF; Taylor RW
Brain; 2008 Feb; 131(Pt 2):329-37. PubMed ID: 18065439
[TBL] [Abstract][Full Text] [Related]
10. Acute and late-onset optic atrophy due to a novel OPA1 mutation leading to a mitochondrial coupling defect.
Nochez Y; Arsene S; Gueguen N; Chevrollier A; Ferré M; Guillet V; Desquiret V; Toutain A; Bonneau D; Procaccio V; Amati-Bonneau P; Pisella PJ; Reynier P
Mol Vis; 2009; 15():598-608. PubMed ID: 19325939
[TBL] [Abstract][Full Text] [Related]
11. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion.
Zanna C; Ghelli A; Porcelli AM; Karbowski M; Youle RJ; Schimpf S; Wissinger B; Pinti M; Cossarizza A; Vidoni S; Valentino ML; Rugolo M; Carelli V
Brain; 2008 Feb; 131(Pt 2):352-67. PubMed ID: 18222991
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial DNA content is decreased in autosomal dominant optic atrophy.
Kim JY; Hwang JM; Ko HS; Seong MW; Park BJ; Park SS
Neurology; 2005 Mar; 64(6):966-72. PubMed ID: 15781809
[TBL] [Abstract][Full Text] [Related]
13. Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy.
Chen Y; Jia X; Wang P; Xiao X; Li S; Guo X; Zhang Q
Mol Vis; 2013; 19():292-302. PubMed ID: 23401657
[TBL] [Abstract][Full Text] [Related]
14. Not only dominant, not only optic atrophy: expanding the clinical spectrum associated with OPA1 mutations.
Nasca A; Rizza T; Doimo M; Legati A; Ciolfi A; Diodato D; Calderan C; Carrara G; Lamantea E; Aiello C; Di Nottia M; Niceta M; Lamperti C; Ardissone A; Bianchi-Marzoli S; Iarossi G; Bertini E; Moroni I; Tartaglia M; Salviati L; Carrozzo R; Ghezzi D
Orphanet J Rare Dis; 2017 May; 12(1):89. PubMed ID: 28494813
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction in an Opa1(Q285STOP) mouse model of dominant optic atrophy results from Opa1 haploinsufficiency.
Kushnareva Y; Seong Y; Andreyev AY; Kuwana T; Kiosses WB; Votruba M; Newmeyer DD
Cell Death Dis; 2016 Jul; 7(7):e2309. PubMed ID: 27468686
[TBL] [Abstract][Full Text] [Related]
16. Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifier.
Bonifert T; Karle KN; Tonagel F; Batra M; Wilhelm C; Theurer Y; Schoenfeld C; Kluba T; Kamenisch Y; Carelli V; Wolf J; Gonzalez MA; Speziani F; Schüle R; Züchner S; Schöls L; Wissinger B; Synofzik M
Brain; 2014 Aug; 137(Pt 8):2164-77. PubMed ID: 24970096
[TBL] [Abstract][Full Text] [Related]
17. OPA1 mutations and mitochondrial DNA haplotypes in autosomal dominant optic atrophy.
Han J; Thompson-Lowrey AJ; Reiss A; Mayorov V; Jia H; Biousse V; Newman NJ; Brown MD
Genet Med; 2006 Apr; 8(4):217-25. PubMed ID: 16617242
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial oxidative phosphorylation in autosomal dominant optic atrophy.
Mayorov VI; Lowrey AJ; Biousse V; Newman NJ; Cline SD; Brown MD
BMC Biochem; 2008 Sep; 9():22. PubMed ID: 18783614
[TBL] [Abstract][Full Text] [Related]
19. Autophagy controls the pathogenicity of OPA1 mutations in dominant optic atrophy.
Kane MS; Alban J; Desquiret-Dumas V; Gueguen N; Ishak L; Ferre M; Amati-Bonneau P; Procaccio V; Bonneau D; Lenaers G; Reynier P; Chevrollier A
J Cell Mol Med; 2017 Oct; 21(10):2284-2297. PubMed ID: 28378518
[TBL] [Abstract][Full Text] [Related]
20. OPA1-related dominant optic atrophy is not strongly influenced by mitochondrial DNA background.
Pierron D; Ferré M; Rocher C; Chevrollier A; Murail P; Thoraval D; Amati-Bonneau P; Reynier P; Letellier T
BMC Med Genet; 2009 Jul; 10():70. PubMed ID: 19619285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
